Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK573719 (Umeclidinium) Dose Finding in COPD
NCT00950807Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of umeclidinium in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Sep 2009; status: completed.
02
Drugs
umeclidinium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00950807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00950807.